LONDON, Sept. 4, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) is unveiling Sea Dagger, a next-generation Commando Insertion Craft (CIC) concept developed for the Royal Navy. The first craft of its size to combine speed, range, vehicle delivery and modular mission systems into a single platform, Sea Dagger sets a new standard in maritime autonomy and operational agility. Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovat ...

PRESS RELEASE 04/09/2025 Security and DefenseLACROIX leverages its industrial and technological expertise in support of French and European sovereignty The intensification of global geopolitical tensions is leading to a major and rapid re-prioritization of defense sector priorities in France and across Europe.The Readiness 2030 Plan (ReArm Europe) provides for the mobilization of €800 billion by 2030, raising defense spending to 3% of the European Union’s GDP. The SAFE Program (Security for Action for ...

Company Overview - Klépierre is the European leader in shopping malls, focusing exclusively on continental Europe [3] - The company's portfolio is valued at €20.6 billion as of June 30, 2025, comprising large shopping centers in over 10 countries [3] - Klépierre attracts more than 700 million visitors annually [3] - The company is a French REIT (SIIC) listed on Euronext Paris and included in the CAC Next 20 and EPRA Euro Zone Indexes [3] Voting Rights Information - As of August 31, 2025, Klépierre has a total of 286,861,172 shares [2] - The number of exercisable voting rights is 286,297,975, accounting for shares deprived of voting rights [2][6] - Klépierre owns 563,197 of its own shares, which are excluded from the exercisable voting rights [5] Sustainability and Ethical Commitment - Klépierre is included in various ethical indexes, such as CAC SBT 1.5, MSCI Europe ESG Leaders, and FTSE4Good, highlighting its commitment to sustainable development [3] - The company features in CDP's "A list," underscoring its leadership in combating climate change [3] Upcoming Events - A trading update for the first nine months of 2025 is scheduled for October 22, 2025, after market closing [3]

Core Insights - Cardinal Health has opened a new distribution center in Fort Worth, Texas, dedicated to its at-Home Solutions business, which serves over 6 million people annually in the U.S. [1] - The Fort Worth facility is the third distribution center built from the ground up in three years, with a size of 340,000 square feet, capable of shipping approximately 10,000 packages daily [2] - The company has expanded its distribution network by over 750,000 square feet in three years, incorporating advanced robotics and automation technology [3] Investment and Expansion - Cardinal Health is committed to investing in its supply chain, emphasizing the necessity of enhancing distribution capabilities to meet customer needs [4] - Plans for further expansion include breaking ground on a new distribution center in Sacramento, California, and retrofitting an existing facility in Ontario, California, with advanced technology [5][6] - The Sacramento facility is expected to be operational by Summer 2027, aimed at improving delivery efficiency on the West Coast [6]

VAISALA CORPORATIONSTOCK EXCHANGE RELEASE 4.9.2025 Vaisala Corporation: Share Repurchase 4.9.2025 In the Helsinki Stock Exchange Trade date 4.9.2025 Bourse trade Buy Share VAIAS Amount 3 700SharesAverage price/ share 44,4676EURTotal cost 164 530,12EUR Vaisala Corporation now holds a total of 170 800 shares<td colspan="2 ...

Core Points - Ultralife Corporation has received a $5.2 million award from the U.S. Government's Defense Logistics Agency for its BA-5390 military batteries, with shipments scheduled throughout 2026 and completion in early 2027 [1] - The BA-5390 battery is recognized for its long life, safety, and reliability, and Ultralife has been a long-standing supplier to the U.S. military [2] - The previous significant award for the BA-5390 battery was a multi-year contract valued at up to $9.9 million received in 2021 [2] Company Overview - Ultralife Corporation provides products and services ranging from power solutions to communications and electronics systems, serving government/defense and commercial customers globally [3] - The company is headquartered in Newark, New York, and operates in North America, Europe, and Asia, with business segments including Battery & Energy Products and Communications Systems [4]

Core Insights - BlockQuarry Corp. has initiated comprehensive testing of its BLQCBuster mining system, with completion expected by early November [1] - The CEO of BlockQuarry expressed confidence that the testing will meet or exceed expectations, with plans to announce miner order acceptance following preliminary results [2] - The BLQCBuster features a modular chip design that enhances mining capability and scalability, positioning BlockQuarry as a leader in next-generation mining infrastructure [3] Company Developments - BlockQuarry is focusing on building a robust backend support system to enhance customer service [4] - The company is set to introduce a customer service program named 'BLQCSmith', aimed at providing quality service and creating jobs in the U.S. [5] - BlockQuarry is committed to advancing carbon-negative industrial energy solutions, catering to industries with high power demands, including cryptocurrency mining and AI [5]

BOCA RATON, FL, Sept. 04, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the acquisition of 196,141 SOL at an average price of $202.76 per token. This purchase brings the Company’s total holdings to 2,027,817 SOL. Below is a summary of DeFi Dev Corp.’s current SOL position and key per-share metrics as of September 4, 2025: Total SOL & SOL Equivalents Held: 2,027, ...

Core Insights - AIM ImmunoTech Inc. presented positive progress on its lead program Ampligen for pancreatic cancer at the 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care, highlighting improvements in Progression-Free Survival and Overall Survival from the DURIPANC clinical trial and Early Access Program [1][2][3] Company Overview - AIM ImmunoTech Inc. is focused on developing therapeutics for various cancers, immune disorders, and viral diseases, with its lead product being Ampligen, a first-in-class investigational drug [5] Clinical Trials and Data - The Phase 2 DURIPANC clinical trial is currently evaluating the combination of Ampligen and AstraZeneca's anti-PD-L1 immune checkpoint inhibitor durvalumab for late-stage metastatic pancreatic cancer patients [3] - The clinical data presented indicates a strong potential for Ampligen in treating late-stage pancreatic cancer, addressing a significant unmet medical need [3] Regulatory and Market Position - Ampligen has patent protection for its combination therapy in the U.S. until 2039 and has received orphan drug designations in both the U.S. and EU, which will provide market protections for an approved drug [3]

EV drivers will be able to seamlessly pay with cryptocurrency at Blink chargers before the end of this year Bowie, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced its innovative move to integrate cryptocurrency payment options across the Blink Network by the end of 2025. This forward-looking direction positions Blink at the intersecti ...